Suni Sreepada is a partner in the Mergers & Acquisitions Practice Group, and is resident in the New York office. Ms. Sreepada focuses on the representation of corporate clients and private equity funds in connection with domestic and global mergers, acquisitions and equity investments in a broad range of industries. She also provides general corporate and corporate governance advice.
Suni is listed as a "Rising Star" for M&A in the United States by Euromoney (2020).
Calpine Corporation (NYSE: CPN) in its US$17 billion sale to Energy Capital Partners and a consortium of investors including Access Industries and Canadian Pension Plan Investment Board.
IFM Investors in its US$10.3 billion acquisition of Buckeye Partners, L.P. (NYSE: BPL). The transaction was named "Private Equity Deal (Over US$10 billion)" by M&A Advisor (2020).
A consortium composed of Brookfield Infrastructure and its institutional partners and GIC on the US$8.4 billion acquisition of Genesee & Wyoming Inc. (NYSE:GWR). The transaction was named "Private Equity Deal of the Year" by IFLR 2020.
LifePoint Health, Inc. (NASDAQ: LPNT) in its US$5.6 billion merger with RCCH HealthCare Partners, which is owned by certain funds managed by affiliates of Apollo Global Management, LLC (NYSE: APO).
Roark Capital Group and its portfolio company Arby's Restaurant Group, in Arby's US$2.9 billion acquisition of Buffalo Wild Wings, Inc. (NASDAQ: BWLD).
Macquarie Infrastructure Corporation in its US$2.685 billion sale of International-Matex Tank Terminals, a bulk liquid terminals business, to Riverstone Holdings LLC.
Roark Capital Group and Inspire Brands, Inc., owner of the Arby's and Buffalo Wild Wings restaurant chains, in Inspire Brands' US$2.3 billion acquisition of Sonic Corp. (NASDAQ: SONC).
Sempra Energy (NYSE: SRE) in the US$1.275 billion acquisition by Oncor Electric Delivery Company LLC, a subsidiary of Sempra Energy, of InfraREIT, Inc.
Special Committee of Cellular Biomedicine Group, Inc. in its sale to a consortium including certain members of CBMG management, CBMG stockholders and financial sponsors.
EchoStar Corporation (NASDAQ: SATS) in the tax-free spin-off and subsequent merger of its broadcast satellite service business, including nine satellites and certain real estate owned by EchoStar, with a subsidiary of DISH Network Corp. (NASDAQ: DISH).
CVC Capital Partners in its investment, together with Silver Lake Partners and KKR, in US$6 billion convertible notes to be issued by Broadcom, a leading designer, developer and global supplier of a broad range of digital and analog semiconductor connectivity solutions, for the purpose of Broadcom's proposed acquisition of Qualcomm in a deal valued at US$121 billion.
American Industrial Partners in the acquisition of Rand Logistics, Inc. (NASDAQ:RLOG), a leading provider of bulk freight shipping services in the Great Lakes region.
Enzymotec Ltd. (NASDAQ: ENZY) in its US$290 million sale to Frutarom Ltd., a flavors and specialty fine ingredients company.
NeuroDerm Ltd. (NASDAQ: NDRM) in its US$1.1 billion sale to Mitsubishi Tanabe Pharma Corporation.
Avast Software in its US$1.3 billion acquisition of AVG Technologies.
Zimmer Biomet (NYSE and SIX: ZBH) in its US$1.1 billion acquisition of LDR Holding Corporation (NASDAQ: LDRH).
Dr. Dennis Gillings, the founder and significant shareholder of Quintiles, in its merger with IMS Health Holdings, creating a company with a combined enterprise value of more than US$23 billion.
AIXTRON SE in its US$750 million sale to Fujian Grand Chip Investment GmbH, a subsidiary of Fujian Grand Chip Investment Fund LP.
Harvest Partners in its partnership with OMERS Private Equity for the US$1 billion acquisition of Epiq Systems, Inc. (NASDAQ: EPIQ) and its combination with Document Technologies Inc.
Morgan Stanley Infrastructure Inc. in its US$619 million acquisition of Seven Seas Water Corporation, AquaVenture Holdings Inc. and AquaVenture Holdings Curacao N.V. from AI Aqua (Luxembourg) S.a.r.l, a company owned by Advent International Corporation.
Lantheus Holdings, Inc. (NASDAQ: LNTH) in its US$500 million acquisition of Progenics Pharmaceuticals, Inc. (NASDAQ: PGNC).
Listed as a "Rising Star" for Mergers & Acquisitions in the United States by Euromoney (2020)